[DISCLOSURE]
ST Pharm (237690) reported on Oct. 25 that its operating profit in the third quarter hiked 22.1 percent to 20.87 billion won (US$ 18.41 million) on a consolidated basis from the same period last year.
Its revenue went up 18 percent to 53.97 billion won and net sales increased 34.3 percent to 16.28 billion won on-year.
By Yun Jeong-hyeon (
clareyun@heraldcorp.com)